
Cachet Pharmaceutical Co., Ltd.
SZSE:002462.SZ
13.64 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 24,018.608 | 29,996.24 | 26,219.79 | 25,625.619 | 23,256.136 | 22,186.573 | 17,959.885 | 14,238.9 | 10,971.577 | 8,199.832 | 5,572.152 | 3,544.275 | 2,554.073 | 1,801.38 | 1,341.671 | 1,133.56 | 965.222 | 662.903 |
Cost of Revenue
| 22,432.154 | 28,018.527 | 24,112.237 | 23,484.862 | 21,121.972 | 19,916.22 | 16,122.289 | 12,858.212 | 9,774.379 | 7,146.698 | 4,854.206 | 3,206.888 | 2,332.013 | 1,630.643 | 1,171.51 | 980.659 | 829.387 | 555.713 |
Gross Profit
| 1,586.454 | 1,977.713 | 2,107.553 | 2,140.757 | 2,134.163 | 2,270.353 | 1,837.596 | 1,380.688 | 1,197.198 | 1,053.134 | 717.946 | 337.387 | 222.06 | 170.737 | 170.161 | 152.901 | 135.834 | 107.19 |
Gross Profit Ratio
| 0.066 | 0.066 | 0.08 | 0.084 | 0.092 | 0.102 | 0.102 | 0.097 | 0.109 | 0.128 | 0.129 | 0.095 | 0.087 | 0.095 | 0.127 | 0.135 | 0.141 | 0.162 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 363.897 | 68.012 | 63.557 | 69.268 | 61.757 | 65.649 | 67.684 | 57.711 | 44.909 | 40.428 | 27.669 | 10.831 | 8.35 | 5.762 | 4.391 | 3.582 | 3.091 | 6.14 |
Selling & Marketing Expenses
| 518.886 | 404.137 | 834.817 | 800.312 | 678.789 | 895.048 | 628.631 | 451.265 | 410.164 | 428.602 | 312.059 | 148.736 | 98.88 | 85.163 | 80.466 | 74.223 | 64.62 | 63.432 |
SG&A
| 882.783 | 472.149 | 898.373 | 869.58 | 740.546 | 960.697 | 696.315 | 508.975 | 455.074 | 469.03 | 339.729 | 159.567 | 107.23 | 90.925 | 84.857 | 77.805 | 67.71 | 69.572 |
Other Expenses
| 135.561 | 949.202 | 263.656 | 234.163 | 192.837 | 196.478 | -2.318 | -2.509 | 7.002 | 4.043 | 4.018 | 29.618 | -0.065 | 15.748 | -0.417 | 0.125 | 4.629 | 2.892 |
Operating Expenses
| 1,018.344 | 1,363.104 | 1,162.029 | 1,103.743 | 933.384 | 1,157.175 | 859.091 | 638.692 | 563.391 | 562.718 | 403.676 | 196.091 | 134.703 | 110.601 | 106.244 | 96.259 | 85.578 | 88.6 |
Operating Income
| 568.11 | 556.362 | 936.891 | 830.766 | 1,194.95 | 891.104 | 777.169 | 631.588 | 545.289 | 399.05 | 406.548 | 164.689 | 91.749 | 69.656 | 65.261 | 56.359 | 50.743 | 212.319 |
Operating Income Ratio
| 0.024 | 0.019 | 0.036 | 0.032 | 0.051 | 0.04 | 0.043 | 0.044 | 0.05 | 0.049 | 0.073 | 0.046 | 0.036 | 0.039 | 0.049 | 0.05 | 0.053 | 0.32 |
Total Other Income Expenses Net
| -16.445 | -1.08 | -186.096 | -149.509 | -266.178 | -175.596 | -170.776 | -94.474 | -71.749 | -74.147 | 110.007 | 29.603 | -0.225 | 15.748 | -0.417 | 0.117 | 4.51 | 196.941 |
Income Before Tax
| 551.664 | 555.282 | 644.906 | 823.979 | 814.307 | 887.55 | 774.851 | 629.079 | 552.243 | 403.04 | 410.52 | 194.291 | 91.525 | 85.405 | 64.845 | 56.476 | 55.253 | 215.108 |
Income Before Tax Ratio
| 0.023 | 0.019 | 0.025 | 0.032 | 0.035 | 0.04 | 0.043 | 0.044 | 0.05 | 0.049 | 0.074 | 0.055 | 0.036 | 0.047 | 0.048 | 0.05 | 0.057 | 0.324 |
Income Tax Expense
| 229.989 | 178.748 | 176.594 | 222.1 | 223.404 | 227.747 | 204.239 | 159.635 | 142.244 | 101.695 | 104.098 | 47.648 | 22.654 | 21.576 | 15.901 | 13.935 | 13.669 | 32.128 |
Net Income
| 160.668 | 250.06 | 468.313 | 601.879 | 590.904 | 659.802 | 327.633 | 263.642 | 223.1 | 172.976 | 228.06 | 130.169 | 65.21 | 63.683 | 48.542 | 42.418 | 41.357 | 182.625 |
Net Income Ratio
| 0.007 | 0.008 | 0.018 | 0.023 | 0.025 | 0.03 | 0.018 | 0.019 | 0.02 | 0.021 | 0.041 | 0.037 | 0.026 | 0.035 | 0.036 | 0.037 | 0.043 | 0.275 |
EPS
| 0.55 | 0.86 | 1.61 | 2.06 | 2.03 | 2.53 | 1.31 | 1.05 | 0.89 | 0.72 | 0.95 | 0.54 | 0.27 | 0.27 | 0.24 | 0.23 | 0.23 | 1.01 |
EPS Diluted
| 0.55 | 0.86 | 1.61 | 2.06 | 2.03 | 2.53 | 1.31 | 1.05 | 0.89 | 0.72 | 0.95 | 0.54 | 0.27 | 0.27 | 0.24 | 0.23 | 0.23 | 1.01 |
EBITDA
| 847.224 | 912.843 | 1,047.211 | 1,177.819 | 1,161.289 | 1,160.232 | 1,018.838 | 769.844 | 670.865 | 506.862 | 463.515 | 217.975 | 104.406 | 92.948 | 75.651 | 64.68 | 60.478 | 28.423 |
EBITDA Ratio
| 0.035 | 0.03 | 0.04 | 0.046 | 0.05 | 0.052 | 0.057 | 0.054 | 0.061 | 0.062 | 0.083 | 0.062 | 0.041 | 0.052 | 0.056 | 0.057 | 0.063 | 0.043 |